SKU: T4306-10mg-TM
CCG-203971
Blue Ice
Specifications
| Specification | Details |
|---|---|
| Additional Information | CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971 causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days. |
| Synonyms | CCG 203971; CCG-203971 |
| Purity | 98.82% |
Resources
PDF
Datasheet
Catalog Number
T4306-10mg-TM
Name
CCG-203971
Price(10 mg)
Pack Size